½ÃÀ庸°í¼­
»óǰÄÚµå
1612238

¼¼°èÀÇ Àΰø¼öÁ¤ ½ÃÀå : Á¦Ç° À¯Çü, ±âÁõÀÚ À¯Çü, ±â¼ú, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Artificial Insemination Market by Product (Accessories, Home Conception Devices, Insemination Kits), Donor Type (Fresh Donor Semen, Frozen Donor Semen), Technique, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àΰø¼öÁ¤ ½ÃÀåÀº 2023³â 31¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 34¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.16%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 54¾ï 9,000¸¸ ´Þ·¯°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àΰø¼öÁ¤(AI)Àº »ý½Ä ÀÇ·á ¹× µ¿¹° ¹ø½Ä¿¡¼­ Áß¿äÇÑ ±â¼úÀÌ¸ç ¾ÏÄÆ »ý½Ä°ü¿¡ Á¤¾×À» ÀǵµÀûÀ¸·Î µµÀÔÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. AI°¡ ÇÊ¿äÇÑ ÀÌÀ¯´Â À¯ÀüÀû °³·®, ¹ø½Ä ¼º°ø·üÀÇ Çâ»ó, ±×¸®°í Ãà»ê¾÷ ÀüüÀÇ Áúº´ ´ëÃ¥ÀÔ´Ï´Ù. ¼Ò, µÅÁö, °¡±Ý, ±×¸®°í ÃÖ±Ù¿¡´Â ¼ö»ê ¾ç½Ä¿¡µµ ³Î¸® ÀÀ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿ëµµ´Â È¿À²ÀûÀÎ ¹ø½Ä ¹æ¹ýÀ» ¿ä±¸ÇÏ´Â ³ó¾÷±â¾÷¿¡¼­ »ý½Äº¸Á¶±â¼úÀ» Á¦°øÇÏ´Â ÀÇ·á½Ã¼³±îÁö ´Ù¾çÇÕ´Ï´Ù. ³«³ó »ý»ê¿¡¼­ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó µ¿¹°ÀÇ °Ç°­°ú ¹ø½ÄÀÇ Áú¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í µµÀÔ·üÀÌ »ó½ÂÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦±¹ÀÇ AI ¾ÖÇø®ÄÉÀÌ¼Ç È®´ë, µ¿°áº¸Á¸ ¹× À¯ÀüÀÚ °Ë»ç¿Í °°Àº AI ±â¼úÀ» Ȱ¿ëÇÏ¿© ¼º°ú¿Í ä¿ë·üÀ» ´ëÆø Çâ»ó½Ãų ¼ö Àֱ⠶§¹®¿¡ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ°¡ ź»ýÇÕ´Ï´Ù. ³óÀå¿ëÀ¸·Î Á¶Á¤µÈ Àúºñ¿ëÀ¸·Î È¿À²ÀûÀÎ AI ¼Ö·ç¼Ç °³¹ß¿¡ ÁßÁ¡À» µÎ¸é ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­ ¼ö¿ä¸¦ ȯ±âÇÒ ¼ö ÀÖ½À´Ï´Ù. ³ôÀº ¼º°ø·ü È®º¸¸¦ À§ÇØ ±â¾÷Àº AI ±â¼úÀÇ °³¼±¿¡ ÁÖ·Â ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ö, ½º¸¶Æ® ³ó¾÷°ú Á¤¹ÐÀǷḦ ÇâÇØ ½ÃÀåÀ» µÞ¹ÞħÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ½ÃÀåÀº ¿ªµ¿ÀûÀÎ ¼ºÁúÀ» ³ªÅ¸³», »çȸ °æÁ¦Àû ¹× ±ÔÁ¦»óÀÇ °úÁ¦°¡ ±Ùº»ÀûÀ¸·Î ÀÖ´Â °¡¿îµ¥, ±â¼úÀÇ Áøº¸¿Í ¹ø½Ä ¹æ¹ýÀÇ ¼¼°èÈ­¿¡ À־ »ó´çÇÑ ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 31¾ï 7,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 34¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 54¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 8.16%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Àΰø¼öÁ¤ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Àΰø¼öÁ¤ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°è ³²¼ºÀÇ ºÒÀÓÀÌ Áõ°¡ÇÏ¿© ÀÓ½ÅÀÌ ¾î·Á¿öÁö°í ÀÖ½À´Ï´Ù.
    • ¼¼°è °¢Áö¿¡¼­ÀÇ ºÒÀÓ Ä¡·á Ŭ¸®´ÐÀ̳ª º´¿øÀÇ È®´ë
    • ¸®ÇÁ·Î´öƼºê Çコ¸¦ °³¼±ÇÏ°í ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Àΰø¼öÁ¤ÀÇ ½Ç½Ã¿¡ À־ÀÇ º¹ÀâÇÔ°ú ¼÷·ÃÀÚÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • Àΰø¼öÁ¤ óġÀÇ Á¤¹Ðµµ¿Í ¼º°ø·üÀ» Çâ»ó½Ã۱â À§ÇÑ Áøº¸
    • °¡Á¤¿ë ºÒÀÓ Ä¡·á ŰƮ¿Í »õ·Î¿î Àΰø¼öÁ¤ ¼Ö·ç¼Ç ½ÂÀÎ
  • ½ÃÀåÀÇ °úÁ¦
    • Àΰø¼öÁ¤¿¡ °üÇÑ À±¸®Àû ¹®Á¦¿Í ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Force : Àΰø¼öÁ¤ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â Àΰø¼öÁ¤ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÇÇÒ ¼ö ÀÖÀ¸¸ç ´õ °­ÀÎÇÑ ½ÃÀå Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àΰø¼öÁ¤ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àΰø¼öÁ¤ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Àΰø¼öÁ¤ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Àΰø¼öÁ¤ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÐ¸íÈ÷ ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Àΰø¼öÁ¤ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àΰø¼öÁ¤ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±âº» °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·«ºÐ¼®°ú Ãßõ : Àΰø¼öÁ¤ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Àΰø¼öÁ¤ ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è ³²¼ºÀÇ ºÒÀÓÀÌ Áõ°¡ÇÏ¿© ÀÓ½ÅÀÌ ¾î·Á¿öÁö°í ÀÖ½À´Ï´Ù
      • Àü ¼¼°è¿¡¼­ ºÒÀÓ Ä¡·á Ŭ¸®´Ð°ú º´¿øÀÌ È®´ë
      • »ý½Äº¸°ÇÀÇ °³¼±°ú Á¢±ÙÈ®´ë¸¦ À§ÇÑ Á¤ºÎÀÇ ´ëó Àΰø¼öÁ¤
    • ¾ïÁ¦¿äÀÎ
      • Àΰø¼öÁ¤ÀÇ ½Ç½ÃÀÇ º¹À⼺°ú ¼÷·ÃµÈ ÀÎÀçÀÇ ºÎÁ·
    • ±âȸ
      • Àΰø¼öÁ¤ ÀýÂ÷ÀÇ Á¤¹Ðµµ¿Í ¼º°ø·üÀ» Çâ»ó½Ã۱â À§ÇÑ Áøº¸
      • Áý¿¡¼­ ÇÒ ¼ö ÀÖ´Â ºÒÀÓ Ä¡·á ŰƮ¿Í »õ·Î¿î Àΰø¼öÁ¤ ¼Ö·ç¼ÇÀÇ ½ÂÀÎ
    • °úÁ¦
      • Àΰø¼öÁ¤°ú °ü·ÃµÈ À±¸®Àû ¹®Á¦¿Í ¾ÈÀü¼º ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç°: º¸´Ù ³ôÀº ÄèÀû¼º°ú Æí¸®¼ºÀ» ½ÇÇöÇÏ´Â °¡Á¤¿ë ¼öÁ¤ ±â±âÀÇ È£°¨µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù
    • ±âÁõÀÚ À¯Çü: µ¿°á °ø¿©ÀÚ Á¤¾×ÀÇ º¸Á¸ Á¶°Ç°ú º¸Á¸¼ºÀ» °³¼±Çϱâ À§ÇÑ Áøº¸
    • ±â¼ú: Àڱó» ¼öÁ¤ÀÇ ¼º°ø·üÀ» Çâ»ó½Ã۱â À§ÇÑ Áö¼ÓÀûÀÎ Á¶»ç
    • ¼­ºñ½º Á¦°ø¾÷ü: IVF ¼¾ÅͰ¡ dzºÎÇÑ ºÒÀÓ Ä¡·á ¼­ºñ½º¿Í ȯÀÚ Äɾ Á¦°øÇÒ ¼ö ÀÖ´Â ´É·Â
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Àΰø¼öÁ¤ ½ÃÀå : Á¦Ç°º°

  • ¾×¼¼¼­¸®
  • °¡Á¤¿ë ¼öÅ ÀåÄ¡
  • Àΰø¼öÁ¤ ŰƮ

Á¦7Àå Àΰø¼öÁ¤ ½ÃÀå : ±âºÎÀÚ À¯Çüº°

  • ½Å¼±ÇÑ ±âÁõÀÚ Á¤¾×
  • µ¿°áÁ¤¾×

Á¦8Àå Àΰø¼öÁ¤ ½ÃÀå : ±â¼úº°

  • Àڱà °æ°ü ³» ¼öÁ¤
  • ³­°ü³» ¼öÁ¤
  • Àڱó» Àΰø¼öÁ¤
  • Áú³» ¼öÁ¤

Á¦9Àå Àΰø¼öÁ¤ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ºÎÀΰú Ŭ¸®´Ð
  • º´¿ø
  • ü¿Ü¼öÁ¤(IVF) ¼¾ÅÍ
  • »ê¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Àΰø¼öÁ¤ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àΰø¼öÁ¤ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àΰø¼öÁ¤ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Mosie Baby, Áý¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â Àΰø¼öÁ¤ ŰƮ¿¡¼­ ÃÖÃÊÀÇ 510(k) ½ÂÀÎÀ» Ãëµæ
    • Femasys Inc., Çõ½ÅÀûÀÎ ºÒÀÓ Ä¡·á ¼Ö·ç¼Ç "FemaSeed"ÀÇ ÆÇ¸Å Çã°¡¸¦ ¹Ì±¹ FDA¿¡¼­ Ãëµæ
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Conceivex Inc.
  • Femasys Inc.
  • Fujifilm Irvine Scientific
  • Hamilton Thorne
  • IMV Technologies
  • INVO Bioscience
  • Mosie Baby
  • Pride Angel
  • Rinovum Women's Health Company
  • Vitrolife AB
JHS 24.12.24

The Artificial Insemination Market was valued at USD 3.17 billion in 2023, expected to reach USD 3.42 billion in 2024, and is projected to grow at a CAGR of 8.16%, to USD 5.49 billion by 2030.

Artificial insemination (AI) is a significant technology in reproductive medicine and animal breeding, involving the deliberate introduction of semen into a female's reproductive tract. This method increases reproductive efficiency and genetic diversity without requiring natural mating. AI is necessitated primarily by the need for genetic improvement, increased reproductive success, and disease control across livestock industries. It is applied significantly in cattle, swine, poultry, and increasingly in aquaculture. In the human context, AI serves as a crucial solution for infertility treatments. The end-use scope of AI spans from agricultural enterprises seeking efficient breeding practices to healthcare facilities providing assisted reproductive techniques. As for market insights, the AI market growth is heavily influenced by technological advancements, rising incidences of infertility, and growing demands in meat and dairy production. There's an upsurge in awareness about animal health and breeding quality, fueling adoption rates. However, challenges such as ethical concerns, high costs of advanced technology, and inconsistent regulatory standards across regions can impede market expansion. Potential opportunities arise from expanding AI applications in emerging economies and leveraging AI techniques like cryopreservation and genetic testing, which can significantly enhance outcomes and adoption rates. Emphasis on developing low-cost, efficient AI solutions tailored for small-scale farms can spur demand, particularly in developing nations. For innovation, businesses can focus on improving AI technologies to increase accuracy in semen analysis and deposition techniques, ensuring higher success rates. Furthermore, integrating digital solutions like AI and IoT can enhance monitoring and maintenance of breeding records and animal health, pushing the market towards smart farming and precision medicine. Overall, the market exhibits a dynamic nature with opportunities for substantial growth in technological advancements and globalization of breeding practices amidst underlying socio-economic and regulatory challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 3.17 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 5.49 billion
CAGR (%) 8.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Insemination Market

The Artificial Insemination Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of male fertility issues across the world and difficulties in conceiving
    • Expansion of fertility clinics and hospitals across the world
    • Government initiatives to improve reproductive health and expand access to artificial insemination
  • Market Restraints
    • Complexities in conducting artificial insemination and lack of skilled personnel
  • Market Opportunities
    • Advancements to improve the accuracy and success rate of artificial insemination procedures
    • Approvals for at-home fertility kits and novel artificial insemination solutions
  • Market Challenges
    • Ethical issues and safety concerns related to artificial insemination

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Insemination Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Insemination Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Insemination Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Insemination Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Insemination Market

A detailed market share analysis in the Artificial Insemination Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Insemination Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Insemination Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Insemination Market

A strategic analysis of the Artificial Insemination Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Insemination Market, highlighting leading vendors and their innovative profiles. These include Conceivex Inc., Femasys Inc., Fujifilm Irvine Scientific, Hamilton Thorne, IMV Technologies, INVO Bioscience, Mosie Baby, Pride Angel, Rinovum Women's Health Company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Artificial Insemination Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Home Conception Devices, and Insemination Kits.
  • Based on Donor Type, market is studied across Fresh Donor Semen and Frozen Donor Semen.
  • Based on Technique, market is studied across Intracervical Insemination, Intratubal Insemination, Intrauterine Insemination, and Intravaginal Insemination.
  • Based on End-User, market is studied across Gynecology Clinics, Hospitals, IVF Centers, and Maternity Homes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of male fertility issues across the world and difficulties in conceiving
      • 5.1.1.2. Expansion of fertility clinics and hospitals across the world
      • 5.1.1.3. Government initiatives to improve reproductive health and expand access to artificial insemination
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in conducting artificial insemination and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements to improve the accuracy and success rate of artificial insemination procedures
      • 5.1.3.2. Approvals for at-home fertility kits and novel artificial insemination solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues and safety concerns related to artificial insemination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for home conception devices to achieve higher comfort and convenience
    • 5.2.2. Donor Type: Advancements to improve storage conditions and preservation of frozen donor semen
    • 5.2.3. Technique: Ongoing research initiatives to improve the success of intrauterine insemination
    • 5.2.4. Service Provider: Ability of IVF centers to provide a plethora of fertility services and patient care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Insemination Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Home Conception Devices
  • 6.4. Insemination Kits

7. Artificial Insemination Market, by Donor Type

  • 7.1. Introduction
  • 7.2. Fresh Donor Semen
  • 7.3. Frozen Donor Semen

8. Artificial Insemination Market, by Technique

  • 8.1. Introduction
  • 8.2. Intracervical Insemination
  • 8.3. Intratubal Insemination
  • 8.4. Intrauterine Insemination
  • 8.5. Intravaginal Insemination

9. Artificial Insemination Market, by End-User

  • 9.1. Introduction
  • 9.2. Gynecology Clinics
  • 9.3. Hospitals
  • 9.4. IVF Centers
  • 9.5. Maternity Homes

10. Americas Artificial Insemination Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Insemination Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Insemination Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mosie Baby receives first 510(k) clearance for at-home artificial insemination kit
    • 13.3.2. Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Conceivex Inc.
  • 2. Femasys Inc.
  • 3. Fujifilm Irvine Scientific
  • 4. Hamilton Thorne
  • 5. IMV Technologies
  • 6. INVO Bioscience
  • 7. Mosie Baby
  • 8. Pride Angel
  • 9. Rinovum Women's Health Company
  • 10. Vitrolife AB
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦